Millstone Evans Group, LLC Novavax Inc Transaction History
Millstone Evans Group, LLC
- $157 Billion
- Q3 2025
A detailed history of Millstone Evans Group, LLC transactions in Novavax Inc stock. As of the latest transaction made, Millstone Evans Group, LLC holds 400 shares of NVAX stock, worth $2,976. This represents 0.0% of its overall portfolio holdings.
Number of Shares
400
Previous 400
-0.0%
Holding current value
$2,976
Previous $2.52 Million
37.62%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding NVAX
# of Institutions
306Shares Held
93.9MCall Options Held
6.07MPut Options Held
10.7M-
Vanguard Group Inc Valley Forge, PA15.2MShares$113 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$88.1 Million0.0% of portfolio
-
Shah Capital Management11.8MShares$87.9 Million45.37% of portfolio
-
State Street Corp Boston, MA6.82MShares$50.8 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY3.94MShares$29.3 Million0.02% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $582M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...